Opko Health (Israel) Valuation Overview

OPK -- Israel Stock  

ILS 1,278  5.00  0.39%

Opko Health holds recent Real Value of S1129.62 per share. The prevailing price of the company is S1278.0. At this time the company appears to be over valued. Macroaxis determines value of Opko Health from analyzing the company fundamentals such as Shares Outstanding of 559.77M, Operating Margin of (22.78)% and Return On Equity of (15.40)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Horizon     30 Days    Login   to change
Opko Health is considered to be number one stock in beta category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about  3.80  of Price to Sales per Beta.

Current Market Valuation

Opko Health Valuation Boundaries

Over Valued
December 15, 2018
1,278
Market Value
1,130
Real Value
Target Odds
  
1,406
Upside
Opko Health is not too risky asset. Calculation of real value of Opko Health is based on 2 months time horizon. Increasing Opko Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Additionally take a look at Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com